WATCHMAN™ Implant Procedure
The WATCHMAN™ LAA Closure Device placement procedure may be done under local or general anaesthesia in a catherisation laboratory setting using a standard transseptal technique. The procedure usually lasts about an hour and the patient is typically in the hospital for 24 hours following the procedure.
Click on animation below to view the WATCHMAN™ LAA Closure Procedure:
A transoesophageal echocardiogram (TOE) is performed to measure the LAA to determine which size WATCHMAN™ Device to be implanted. After the inter- atrial septum is crossed using a standard transseptal access system, the WATCHMAN™ Access Sheath and Dilator are advanced over a guidewire into the left atrium. The Access Sheath is then carefully advanced into the distal portion of the LAA over a pigtail catheter. The WATCHMAN™ Delivery System is prepped, inserted into the Access Sheath, and slowly advanced under fluoroscopic guidance. The WATCHMAN™ Device is then deployed into the LAA. The device release criteria are confirmed via fluoroscopy and prior to releasing the Device.
What happens after the WATCHMAN™ device is implanted?
It takes at least 45 days for the heart tissue to heal. During that time, it’s important to continue taking blood thinning medication (Warfarin) and a daily Aspirin. At 45 days, a repeat transoesophageal echo will be performed to check the WATCHMAN™ device. At this time blood thinning medication may be discontinued and Plavix® or clopidogrel is prescribed.
What are the risks of the WATCHMAN™ LAA Closure Device?
Clinical studies show that the WATCHMAN™ device can be safely implanted. However, like for any procedure, there are risks associated with the implantation of the WATCHMAN™ device. These risks will be explained by the implanting physician.
Who can benefit?
Patients who have non-valvular atrial fibrillation who require treatment for potential blood clot formation and can take anticoagulation medication such as Warfarin may be eligible to be treated with the WATCHMAN™ device.
Do you have atrial fibrillation that requires you to be on anticoagulant therapy?
If so, you may be eligible for treatment with the WATCHMAN™ device that may replace your need for long term anticoagulant therapy. Ask your doctor if you are a candidate for this treatment.
This product is included on the Australian Register of Therapeutic Goods and is listed on the New Zealand WAND Database.
The material presented on this website is for general informational purposes only and is intended primarily for use by referring physicians. Patients who would like additional details should contact their physician who will determine whether or not this particular device is suitable for them.
ANZ_PSST_12069 Rev C | August 2013